Sort
39,280 grants matching “leukemia”
Exploring oncogenic translation programs in cancer
$406,648Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Exploring oncogenic translation programs in cancer
$406,648Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Clinical Trials Shared Resource
$406,483Jordan D Berlin · Vanderbilt University · P30 · FY2010 · CA
MBRS PROGRAM
$406,433Colorado State University-Pueblo · S06 · FY2000 · GM
EPIDEMIOLOGY OF DOWN SYNDROME--LEUKEMIA &DOWN SYNDROME
$406,420University Of Minnesota Twin Cities · R01 · FY2000 · CA
Pharmacogenetic Determinants of Vincristine Toxicity and Response
$406,355Jamie L Renbarger · Indiana University Indianapolis · R01 · FY2013 · HD
Pathogenesis of Notch Leukemia
$406,342Brigham And Women'S Hospital · R01 · FY2003 · CA
PATHOGENESIS OF NOTCH 1 LEUKEMIA
$406,342Brigham And Women'S Hospital · R01 · FY2002 · CA
Role of the Histone Methyltransferase MLL4 in Medulloblastoma
$406,341Min Gyu Lee · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer
$406,336Qing Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Natural Products Synthesis via Cycloaddition Reactions
$406,331William R Roush · Scripps Florida · R01 · FY2010 · GM
Core D: Biospecimen and Pathology Core
$406,317Andrea Marcogliese Sheehan · Baylor College Of Medicine · P50 · FY2023 · CA
Redox Regulation of SERCA by Nitric Oxide
$406,250Richard A Cohen · Boston University Medical Campus · R01 · FY2010 · HL
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$406,245Jing Zhang · University Of Wisconsin-Madison · R01 · FY2023 · CA
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$406,245Jing Zhang · University Of Wisconsin-Madison · R01 · FY2025 · CA
Pharmacokinetic / Pharmacodynamic Optimization of ADC Therapy for Acute Myeloid Leukemia
$406,193Joseph P Balthasar · State University Of New York At Buffalo · R01 · FY2024 · CA
Molecular and Pharmacologic Correletes of Acute Myeloid Leukemia in Down Syndrome
$406,183Jeffrey W Taub · Wayne State University · R01 · FY2008 · CA
Development Of P2Y Receptor Ligands
$406,169Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
$406,080Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2022 · CA
The Novel Role and Mechanism of RBM33 in Leukemogenesis
$406,049Zhijian Qian · University Of Florida · R01 · FY2022 · CA
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
$406,038Constantine S. Mitsiades · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Structural basis of Jak3-mediated interleukin-2 family signal transduction
$406,000Titus Jonathon Boggon · Yale University · R01 · FY2007 · AI
Cancer and Leukemia Group B CCOP Research Base
$405,901Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2012 · CA
Regulation of Monocyte and Granulocyte Lineage Specification
$405,900Alan D Friedman · Johns Hopkins University · R01 · FY2012 · HL
CHILDRENS CANCER GROUP
$405,880Children'S Hospital Of Philadelphia · U10 · FY2002 · CA